Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Eur J Surg Oncol6 Mar 2024

Cautionary Insights on Lymphadenectomy in Modern Liver Surgery

Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma, and colorectal liver metastases were analyzed in 3456 patients undergoing liver resection. Lymphadenectomy was performed in 16% of cases, with the highest rate seen in robotic-assisted resections. However, it was associated with an increased risk of…

Eur J Surg Oncol6 Mar 2024

Survival Benefit of Adjuvant Chemotherapy in Resected Gallbladder Adenocarcinoma

Adjuvant chemotherapy (AC) shows a significant survival advantage in patients with resected gallbladder adenocarcinoma, according to a retrospective cohort analysis. Factors like age, tumor grade, and stage were identified as independent prognostic factors. Poor/undifferentiated tumor histology, higher tumor stage, and lymph node involvement were also…

Langenbecks Arch Surg6 Mar 2024

Higher Radicality and Safety of Laparoscopic RAMPS Compared to LDP with Splenectomy for Distal Pancreatic Adenocarcinoma

Laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) showed significantly higher rates of R0 resection (91.7% vs. 69.2%) and similar intraoperative blood loss and operative time compared to laparoscopic distal pancreatectomy with splenectomy. Both procedures had similar perioperative complication rates. The study demonstrates that laparoscopic RAMPS is…

HPB (Oxford)6 Mar 2024

Identification of Pancreatic Ductal Adenocarcinoma Subtypes Associated with Survival Outcomes

Pancreatic ductal adenocarcinoma patients exhibit varied responses to therapy, with molecular subtyping revealing classical and basal-like subtypes, the latter associated with poorer outcomes. Two main tumor subtypes were identified, along with high-risk stromal subtypes linked to worse survival. Superior survival was seen with classical subtype.…

Langenbecks Arch Surg5 Mar 2024

Comparable Survival Outcomes in Gallbladder Cancer Patients with Acute Cholecystitis

Patients with gallbladder cancer presenting with acute cholecystitis had a 20% overall 5-year survival rate, with stage-specific survival rates varying. A third of patients with gallbladder cancer presented with acute cholecystitis but did not experience significantly different survival outcomes compared to other presentations. Age, gender,…

J Clin Med5 Mar 2024

Platelet Count Ratio Predicts Long-Term Survival in Left Pancreatectomy for PDAC

After left pancreatectomy for pancreatic adenocarcinoma, patients with a perioperative platelet count ratio (PPR) ≥ 1.5 had significantly longer median overall survival (OS) compared to those with PPR < 1.5 (40 months vs. 20 months). PPR was identified as a biomarker for predicting long-term survival…

Langenbecks Arch Surg4 Mar 2024

Impact of Right Hepatic Artery Anomalies on Pancreatoduodenectomy Outcomes

In periampullary cancer patients undergoing pancreatoduodenectomy, anomalies in the right hepatic artery (RHA) anatomy, including accessory or replaced RHAs, were observed in 16.3% of cases. However, when comparing outcomes with a propensity score-matched analysis, the presence of these anomalies did not significantly impact perioperative complications…